Literature DB >> 26715031

Regulation of Posttranslational Modifications of HMGB1 During Immune Responses.

Yiting Tang1,2,3, Xin Zhao1,2, Daniel Antoine4, Xianzhong Xiao5,6, Haichao Wang7, Ulf Andersson8, Timothy R Billiar9, Kevin J Tracey10, Ben Lu1,2,5,10.   

Abstract

SIGNIFICANCE: High-mobility group protein 1 (HMGB1) is an evolutionarily conserved and multifunctional protein. The biological function of HMGB1 depends on its cellular locations, binding partners, and redox states. Extracellular HMGB1 is a mediator of inflammation during infection or tissue injury. Immune cells actively release HMGB1 in response to infection, which in turn orchestrates both innate and adaptive immune responses. RECENT ADVANCES: Hyperacetylation of HMGB1 within its nuclear localization sequences mobilizes HMGB1 from the nucleus to the cytoplasm and subsequently promotes HMGB1 release. The redox states of the cysteines in positions 23, 45, and 106 determine the biological activity of the extracellular HMGB1. CRITICAL ISSUES: The full picture and the detailed molecular mechanisms of how cells regulate the posttranslational modifications and the redox status of HMGB1 during immune responses or under stress not only unravel the molecular mechanisms by which cells regulate the release and the biological function of HMGB1 but may also provide novel therapeutic targets to treat inflammatory diseases. FUTURE DIRECTIONS: It is important to identify the signaling pathways that regulate the posttranslational modifications and the redox status of HMGB1 and find their roles in host immune responses and pathogenesis of diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26715031      PMCID: PMC5349223          DOI: 10.1089/ars.2015.6409

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  98 in total

1.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

2.  Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.

Authors:  Maria Entezari; Daniel J Weiss; Ravikumar Sitapara; Laurie Whittaker; Matthew J Wargo; JianHua Li; Haichao Wang; Huan Yang; Lokesh Sharma; Binh D Phan; Mohammad Javdan; Sangeeta S Chavan; Edmund J Miller; Kevin J Tracey; Lin L Mantell
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

3.  Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages.

Authors:  Xianghong Zhang; David Wheeler; Ying Tang; Lanping Guo; Richard A Shapiro; Thomas J Ribar; Anthony R Means; Timothy R Billiar; Derek C Angus; Matthew R Rosengart
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition.

Authors:  Madhusudan Dey; Chune Cao; Arvin C Dar; Tomohiko Tamura; Keiko Ozato; Frank Sicheri; Thomas E Dever
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

5.  HMGB1: a novel Beclin 1-binding protein active in autophagy.

Authors:  Rui Kang; Kristen M Livesey; Herbert J Zeh; Michael T Loze; Daolin Tang
Journal:  Autophagy       Date:  2010-11-16       Impact factor: 16.016

6.  IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism.

Authors:  Beatriz Rendon-Mitchell; Mahendar Ochani; Jianhua Li; Jialian Han; Hong Wang; Huan Yang; Seenu Susarla; Christopher Czura; Robert A Mitchell; Guoqian Chen; Andrew E Sama; Kevin J Tracey; Haichao Wang
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

7.  HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4.

Authors:  Jean-Marc Tadie; Hong-Beom Bae; Shaoning Jiang; Dae Won Park; Celeste P Bell; Huan Yang; Jean-Francois Pittet; Kevin Tracey; Victor J Thannickal; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-11       Impact factor: 5.464

8.  Tunable signal processing through modular control of transcription factor translocation.

Authors:  Nan Hao; Bogdan A Budnik; Jeremy Gunawardena; Erin K O'Shea
Journal:  Science       Date:  2013-01-25       Impact factor: 47.728

9.  Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway.

Authors:  Ju-Hyun Kim; Seon-Ju Kim; Im-Soon Lee; Myung-Shik Lee; Satoshi Uematsu; Shizuo Akira; Kwon Ik Oh
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

10.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

View more
  40 in total

1.  PCV2 Induces Reactive Oxygen Species To Promote Nucleocytoplasmic Translocation of the Viral DNA Binding Protein HMGB1 To Enhance Its Replication.

Authors:  Renjie Sun; Siqi Sun; Yikai Zhang; Yingshan Zhou; Ying Shan; Xiaoliang Li; Weihuan Fang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 2.  Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation.

Authors:  Meihong Deng; Melanie J Scott; Jie Fan; Timothy R Billiar
Journal:  J Leukoc Biol       Date:  2019-04-04       Impact factor: 4.962

3.  Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes.

Authors:  Huan Yang; Haichao Wang; Yaakov A Levine; Manoj K Gunasekaran; Yongjun Wang; Meghan Addorisio; Shu Zhu; Wei Li; Jianhua Li; Dominique Pv de Kleijn; Peder S Olofsson; H Shaw Warren; Mingzhu He; Yousef Al-Abed; Jesse Roth; Daniel J Antoine; Sangeeta S Chavan; Ulf Andersson; Kevin J Tracey
Journal:  JCI Insight       Date:  2016-05-19

4.  Gender Difference in Damage-Mediated Signaling Contributes to Pulmonary Arterial Hypertension.

Authors:  Ruslan Rafikov; Vineet Nair; Shripad Sinari; Harini Babu; Jennifer C Sullivan; Jason X-J Yuan; Ankit A Desai; Olga Rafikova
Journal:  Antioxid Redox Signal       Date:  2019-03-20       Impact factor: 8.401

5.  Double-Stranded RNA Dependent Kinase R Regulates Antibacterial Immunity in Sepsis.

Authors:  Yanliang Yang; Lingli Xie; Yanjun Zhong; Xiaoli Zhong; Ran Meng; Qianqian Xue; Fang Liang; Kai Zhao; Yiting Tang
Journal:  J Innate Immun       Date:  2020-12-17       Impact factor: 7.349

6.  Inhibition of HMGB1 reduced high glucose-induced BMSCs apoptosis via activation of AMPK and regulation of mitochondrial functions.

Authors:  Beilei Liu; Xueqi Gan; Yuwei Zhao; Jing Gao; Haiyang Yu
Journal:  J Physiol Biochem       Date:  2021-02-26       Impact factor: 4.158

Review 7.  Biomarkers of drug-induced liver injury.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Adv Pharmacol       Date:  2019-03-06

8.  PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.

Authors:  Qian Li; Zhuo-Ming Li; Shu-Ya Sun; Lu-Ping Wang; Pan-Xia Wang; Zhen Guo; Han-Wei Yang; Jian-Tao Ye; Jing Lu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-07-20       Impact factor: 6.150

Review 9.  Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy.

Authors:  Swati Bhattacharyya; John Varga
Journal:  Immunol Lett       Date:  2017-09-28       Impact factor: 3.685

Review 10.  Molecular insights into the therapeutic promise of targeting HMGB1 in depression.

Authors:  Tarapati Rana; Tapan Behl; Vineet Mehta; Md Sahab Uddin; Simona Bungau
Journal:  Pharmacol Rep       Date:  2020-10-04       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.